✦ LIBER ✦

23 Clinical Status of RAF/MEK Inhibitors

✍ Scribed by Weber, J.; Daud, A.; Infante, J.; Sosman, J.; Flaherty, K.; Kefford, R.; Hamid, O.; Schuchter, L.; Patel, K.; Gonzalez, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitors of Raf kinase and MEK signali

✍ Nithya Ramnath; Alex Adjei 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 469 KB

The “SWOT” of BRAF Inhibition in Melanom

✍ Moriah H. Nissan; David B. Solit 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 409 KB

The clinical development of MEK inhibito

✍ Zhao, Yujie; Adjei, Alex A. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 918 KB

Optimizing the Physicochemical Propertie

✍ Aoki, Toshihiro; Hyohdoh, Ikumi; Furuichi, Noriyuki; Ozawa, Sawako; Watanabe, Fu 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 578 KB

Clinical experience of MEK inhibitors in

✍ Ding Wang; Scott A. Boerner; James D. Winkler; Patricia M. LoRusso 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

162 MEK162 (ARRY-162), a novel MEK 1/2 i

✍ S. Winski; D. Anderson; K. Bouhana; R. Impastato; R. Woessner; J. Zuzack; B. Tun 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB